These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 21881038)

  • 1. Early-stage progress on glioma vaccines.
    Brower V
    J Natl Cancer Inst; 2011 Sep; 103(18):1361-2. PubMed ID: 21881038
    [No Abstract]   [Full Text] [Related]  

  • 2. Neuro-oncology: the growing role of chemotherapy in glioma.
    Carpentier AF
    Lancet Neurol; 2005 Jan; 4(1):4-5. PubMed ID: 15620846
    [No Abstract]   [Full Text] [Related]  

  • 3. Cancer vaccines: a novel strategy to sensitize malignant glioma to chemotherapy.
    Liu G; Yu JS
    Expert Rev Neurother; 2007 Oct; 7(10):1235-7. PubMed ID: 17939761
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunotherapy for glioblastoma: the devil is in the details.
    Lesniak MS
    J Clin Oncol; 2011 Aug; 29(22):3105; author reply 3105-6. PubMed ID: 21709193
    [No Abstract]   [Full Text] [Related]  

  • 5. Tumor fighter.
    Kiser K
    Minn Med; 2012 Jan; 95(1):16-9. PubMed ID: 22355905
    [No Abstract]   [Full Text] [Related]  

  • 6. Adaptive Immune Response to and Survival Effect of Temozolomide- and Valproic Acid-induced Autophagy in Glioblastoma.
    Proske J; Walter L; Bumes E; Hutterer M; Vollmann-Zwerenz A; Eyüpoglu IY; Savaskan NE; Seliger C; Hau P; Uhl M
    Anticancer Res; 2016 Mar; 36(3):899-905. PubMed ID: 26976976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temozolomide for malignant brain tumours.
    Batchelor T
    Lancet; 2000 Apr; 355(9210):1115-6. PubMed ID: 10791369
    [No Abstract]   [Full Text] [Related]  

  • 8. [Anti-glioma vaccination].
    Delhaye M; Clavreul A; Garcion E; Menei P
    Neurochirurgie; 2003 Sep; 49(4):459-63. PubMed ID: 14526258
    [No Abstract]   [Full Text] [Related]  

  • 9. [Peptide vaccination in glioblastoma].
    Terasaki M; Morioka M
    Gan To Kagaku Ryoho; 2014 Jun; 41(6):725-9. PubMed ID: 25167577
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunotherapy offers a promising bet against brain cancer.
    Eisenstein M
    Nature; 2018 Sep; 561(7724):S42-S44. PubMed ID: 30258155
    [No Abstract]   [Full Text] [Related]  

  • 11. Superselective intra-arterial cerebral infusion of novel agents after blood-brain disruption for the treatment of recurrent glioblastoma multiforme: a technical case series.
    Shin BJ; Burkhardt JK; Riina HA; Boockvar JA
    Neurosurg Clin N Am; 2012 Apr; 23(2):323-9, ix-x. PubMed ID: 22440875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacotherapy for adults with tumors of the central nervous system.
    Schor NF
    Pharmacol Ther; 2009 Mar; 121(3):253-64. PubMed ID: 19091301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent medical management of glioblastoma.
    Johnson DR; Chang SM
    Adv Exp Med Biol; 2012; 746():26-40. PubMed ID: 22639157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular-based immunotherapies for patients with glioblastoma multiforme.
    Xu X; Stockhammer F; Schmitt M
    Clin Dev Immunol; 2012; 2012():764213. PubMed ID: 22474481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer vaccines in glioma: how to balance the challenges of small trials, efficiency, and potential adverse events.
    Lowenstein PR
    J Clin Oncol; 2010 Nov; 28(31):4670-3. PubMed ID: 20921460
    [No Abstract]   [Full Text] [Related]  

  • 16. Standard of care and future pharmacological treatment options for malignant glioma: an urgent need for screening and identification of novel tumor-specific antigens.
    Batich KA; Sampson JH
    Expert Opin Pharmacother; 2014 Oct; 15(14):2047-61. PubMed ID: 25139628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccines for glioblastoma and high-grade glioma.
    Wheeler CJ; Black KL
    Expert Rev Vaccines; 2011 Jun; 10(6):875-86. PubMed ID: 21692706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mahaley Clinical Research Award: chemosensitization of glioma through dendritic cell vaccination.
    Yu JS; Luptrawan A; Black KL; Liu G
    Clin Neurosurg; 2006; 53():345-51. PubMed ID: 17380773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of malignant glioma--quo vadis?
    Stupp R; Hottinger AF
    Onkologie; 2008 Jun; 31(6):300-2. PubMed ID: 18547969
    [No Abstract]   [Full Text] [Related]  

  • 20. Evolving strategies: future treatment of glioblastoma.
    Chamberlain M
    Expert Rev Neurother; 2011 Apr; 11(4):519-32. PubMed ID: 21469925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.